Wells Fargo’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-20
| Closed | – | – | 6516 |
|
|
2019
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 6424 |
|
|
2019
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 6393 |
|
|
2019
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 6274 |
|
|
2018
Q4 | $0 | Sell |
20
-309
| -94% | – | ﹤0.01% | 6163 |
|
|
2018
Q3 | $1K | Hold |
329
| – | – | ﹤0.01% | 5865 |
|
|
2018
Q2 | $1K | Sell |
329
-8,713
| -96% | -$26.5K | ﹤0.01% | 5865 |
|
|
2018
Q1 | $31K | Buy |
9,042
+39
| +0.4% | +$134 | ﹤0.01% | 5390 |
|
|
2017
Q4 | $28K | Buy |
9,003
+7,640
| +561% | +$23.8K | ﹤0.01% | 5378 |
|
|
2017
Q3 | $9K | Buy |
1,363
+1,034
| +314% | +$6.83K | ﹤0.01% | 5544 |
|
|
2017
Q2 | $3K | Buy |
329
+20
| +6% | +$182 | ﹤0.01% | 5643 |
|
|
2017
Q1 | $3K | Hold |
309
| – | – | ﹤0.01% | 5690 |
|
|
2016
Q4 | $3K | Buy |
+309
| New | +$3K | ﹤0.01% | 5672 |
|